Geron Corp (GERN)
3.865
-0.04
(-0.90%)
USD |
NASDAQ |
May 16, 12:44
Geron Cash from Operations (TTM): -183.63M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -183.63M |
December 31, 2023 | -167.74M |
September 30, 2023 | -161.99M |
June 30, 2023 | -140.73M |
March 31, 2023 | -139.77M |
December 31, 2022 | -127.38M |
September 30, 2022 | -114.37M |
June 30, 2022 | -107.62M |
March 31, 2022 | -96.80M |
December 31, 2021 | -95.56M |
September 30, 2021 | -86.00M |
June 30, 2021 | -78.61M |
March 31, 2021 | -73.19M |
December 31, 2020 | -66.65M |
September 30, 2020 | -64.40M |
June 30, 2020 | -60.94M |
March 31, 2020 | -57.28M |
December 31, 2019 | -43.83M |
September 30, 2019 | -36.47M |
June 30, 2019 | -30.63M |
March 31, 2019 | -26.38M |
December 31, 2018 | -21.01M |
September 30, 2018 | -22.39M |
June 30, 2018 | -20.67M |
March 31, 2018 | -20.62M |
Date | Value |
---|---|
December 31, 2017 | -20.56M |
September 30, 2017 | -16.77M |
June 30, 2017 | -18.90M |
March 31, 2017 | -20.10M |
December 31, 2016 | -18.37M |
September 30, 2016 | -23.02M |
June 30, 2016 | -21.37M |
March 31, 2016 | -22.07M |
December 31, 2015 | -24.20M |
September 30, 2015 | 9.532M |
June 30, 2015 | 9.965M |
March 31, 2015 | 11.15M |
December 31, 2014 | 9.35M |
September 30, 2014 | -25.93M |
June 30, 2014 | -27.18M |
March 31, 2014 | -29.96M |
December 31, 2013 | -36.68M |
September 30, 2013 | -40.30M |
June 30, 2013 | -48.95M |
March 31, 2013 | -54.79M |
December 31, 2012 | -55.15M |
September 30, 2012 | -66.10M |
June 30, 2012 | -65.99M |
March 31, 2012 | -66.27M |
December 31, 2011 | -62.39M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-183.63M
Minimum
Mar 2024
-30.63M
Maximum
Jun 2019
-96.68M
Average
-90.78M
Median
Cash from Operations (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | -389.32M |
SELLAS Life Sciences Group Inc | -31.41M |
Johnson & Johnson | 23.19B |
Pfizer Inc | 8.578B |
Immuneering Corp | -50.04M |